Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Glioma Diagnosis and Treatment, and Genetic Associations and Epidemiology.
Unmasking Compound Heterozygosity in GYG1 Myopathy: Diagnostic Insights From RNA-Seq and Long-Read Genomics.
Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia
Concurrent immune checkpoint inhibitor associated necrotizing myopathy and acute inflammatory demyelinating polyneuropathy following pembrolizumab therapy
Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.
Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencing.
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit
Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis.
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Deep Intronic <i>FGF14</i> GAA Repeat Expansion in Late-Onset Cerebellar Ataxia
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
MicroRNA-210 regulates the metabolic and inflammatory status of primary human astrocytes.
18F-MK-6240 tau-PET in genetic frontotemporal dementia.
Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90.
Human Oligodendrocyte Myelination Potential; Relation to Age and Differentiation.
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
Regional and age-related diversity of human mature oligodendrocytes.
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
Radiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans.
Autopsy Human Brain Dissection Protocol for Common Age-Related Neurodegenerative Disorders.
Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.
Vessel Wall Enhancement on Black-Blood MRI Predicts Acute and Future Stroke in Cerebral Amyloid Angiopathy
Vessel Wall Enhancement on Black-Blood MRI Predicts Acute and Future Stroke in Cerebral Amyloid Angiopathy.
Theoretical impact of the AT(N) framework on dementia using a community autopsy sample.
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic).
CNS inflammation and neurodegeneration: sequelae of peripheral inoculation with spinal cord tissue in rat.
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Biomarkers for Alzheimer's Disease.